CSPHF
Price
$0.52
Change
+$0.24 (+85.71%)
Updated
Feb 27 closing price
Capitalization
505M
WINT
Price
$1.30
Change
+$0.07 (+5.69%)
Updated
Apr 4 closing price
Capitalization
974.14K
Ad is loading...

CSPHF vs WINT

Header iconCSPHF vs WINT Comparison
Open Charts CSPHF vs WINTBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.52
Change+$0.24 (+85.71%)
Volume$5K
Capitalization505M
Windtree Therapeutics
Price$1.30
Change+$0.07 (+5.69%)
Volume$1.66M
Capitalization974.14K
CSPHF vs WINT Comparison Chart
Loading...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. WINT commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and WINT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (CSPHF: $0.52 vs. WINT: $1.30)
Brand notoriety: CSPHF and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 162% vs. WINT: 110%
Market capitalization -- CSPHF: $505M vs. WINT: $974.14K
CSPHF [@Biotechnology] is valued at $505M. WINT’s [@Biotechnology] market capitalization is $974.14K. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than CSPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WINT’s TA Score shows that 5 TA indicator(s) are bullish.

  • WINT’s TA Score: 5 bullish, 2 bearish.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while WINT (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

WINT is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($505M) has a higher market cap than WINT($974K). CSPHF YTD gains are higher at: 129.756 vs. WINT (-92.557).
CSPHFWINTCSPHF / WINT
Capitalization505M974K51,848%
EBITDAN/A-9.36M-
Gain YTD129.756-92.557-140%
P/E RatioN/A0.83-
RevenueN/A0-
Total CashN/A917K-
Total DebtN/A2.01M-
FUNDAMENTALS RATINGS
WINT: Fundamental Ratings
WINT
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
WINT
RSI
ODDS (%)
Bullish Trend 18 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 18 days ago
69%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NHHHF0.02N/A
N/A
FUELPOSITIVE CORP.
AXAHY40.73-3.25
-7.39%
AXA
CXBMF1.93-0.17
-8.28%
Calibre Mining Corp.
ALSMY1.95-0.21
-9.72%
Alstom
SCGLY7.56-0.95
-11.11%
Societe Generale

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
WINT - CSPHF
24%
Poorly correlated
+5.69%
BCAB - CSPHF
9%
Poorly correlated
-6.57%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
-3.40%
More